Ignite Creation Date:
2024-05-06 @ 6:40 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05746143
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2023-02-07
Brief Title:
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
Sponsor:
University of Southern California
Organization:
University of Southern California
Study Overview
Official Title:
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion A Randomized Control Trial
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery
Detailed Description:
Patients who are undergoing one- to three-level spinal fusion for degenerative lumbar disease will be recruited They will be randomized to either receive zolpidem or placebo two days preoperatively and five days postoperatively
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None